Murugan Kalimutho
Title
Cited by
Cited by
Year
Targeted therapies for triple-negative breast cancer: combating a stubborn disease
M Kalimutho, K Parsons, D Mittal, JA López, S Srihari, KK Khanna
Trends in pharmacological sciences 36 (12), 822-846, 2015
2132015
Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer
M Kalimutho, GDV Blanco, S Di Cecilia, P Sileri, M Cretella, F Pallone, ...
Journal of gastroenterology 46 (12), 1391-1402, 2011
1312011
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer
M Kalimutho, S Di Cecilia, GDV Blanco, F Roviello, P Sileri, M Cretella, ...
British journal of cancer 104 (11), 1770-1778, 2011
1192011
AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer
PD Dunne, DG McArt, JK Blayney, M Kalimutho, S Greer, T Wang, ...
Clinical Cancer Research 20 (1), 164-175, 2014
952014
Adenosine 2B receptor expression on cancer cells promotes metastasis
D Mittal, D Sinha, D Barkauskas, A Young, M Kalimutho, K Stannard, ...
Cancer research 76 (15), 4372-4382, 2016
942016
Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
F Al-Ejeh, PT Simpson, JM Sanus, K Klein, M Kalimutho, W Shi, ...
Oncogenesis 3 (4), e100-e100, 2014
882014
Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis
J Jeffery, D Sinha, S Srihari, M Kalimutho, KK Khanna
Oncogene 35 (6), 683-690, 2016
872016
Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma
LF de Andrade, SF Ngiow, K Stannard, S Rusakiewicz, M Kalimutho, ...
Cancer research 74 (24), 7298-7308, 2014
852014
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer
S Van Schaeybroeck, M Kalimutho, PD Dunne, R Carson, W Allen, ...
Cell reports 7 (6), 1940-1955, 2014
782014
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis
CE Bond, DM McKeone, M Kalimutho, ML Bettington, SA Pearson, ...
Oncotarget 7 (43), 70589, 2016
612016
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis
CE Bond, DM McKeone, M Kalimutho, ML Bettington, SA Pearson, ...
Oncotarget 7 (43), 70589, 2016
612016
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T Boulding, RD McCuaig, A Tan, K Hardy, F Wu, J Dunn, M Kalimutho, ...
Scientific reports 8 (1), 1-18, 2018
562018
Mechanisms of genomic instability in breast cancer
PHG Duijf, D Nanayakkara, K Nones, S Srihari, M Kalimutho, KK Khanna
Trends in molecular medicine 25 (7), 595-611, 2019
372019
CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer
M Kalimutho, D Sinha, J Jeffery, K Nones, S Srihari, WC Fernando, ...
EMBO molecular medicine 10 (9), e8566, 2018
372018
Patterns of genomic instability in breast cancer
M Kalimutho, K Nones, S Srihari, PHG Duijf, N Waddell, KK Khanna
Trends in pharmacological sciences 40 (3), 198-211, 2019
342019
Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma
F Al-Ejeh, M Pajic, W Shi, M Kalimutho, M Miranda, AM Nagrial, A Chou, ...
Clinical Cancer Research 20 (12), 3187-3197, 2014
332014
Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance
M Kalimutho, A Minutolo, S Grelli, A Formosa, G Sancesario, A Valentini, ...
Cancer chemotherapy and pharmacology 67 (6), 1299-1312, 2011
312011
A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection
M Kalimutho, GDV Blanco, M Cretella, E Mannisi, P Sileri, A Formosa, ...
International journal of colorectal disease 26 (5), 583-592, 2011
282011
Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach
S Srihari, M Kalimutho, S Lal, J Singla, D Patel, PT Simpson, KK Khanna, ...
Molecular BioSystems 12 (3), 963-972, 2016
272016
Cep55 overexpression causes male‐specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling
D Sinha, M Kalimutho, J Bowles, AL Chan, DJ Merriner, AL Bain, ...
The FASEB Journal 32 (9), 4984-4999, 2018
232018
The system can't perform the operation now. Try again later.
Articles 1–20